Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-01-22 00:00:00 ET · period of report 2024-01-19 · accession 0001127602-24-001841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-22 | 2024-01-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $6.67 | +12.5K | 454.3K | +3% | +$83.4K |
| D | 2024-01-22 | 2024-01-19 | CYTK | Blum Robert I | Pres, CEO, Dir | S - Sale+OE | $81.42 | -12.5K | 441.8K | -3% | -$1.02M |
| D | 2024-01-22 | 2024-01-19 | CYTK | Blum Robert I | Pres, CEO, Dir | M - OptEx | $0.00 | -12.5K | 143.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-19 | M | A | 12,500 | $6.67 | 454,297 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-19 | S | D | 12,500 | $81.42 | 441,797 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-01-19 | M | D | 12,500 | $0.00 | 143,494 | D | $6.67 · 2016-03-23 to 2026-02-23 | 12,500 Common Stock |